Recommendations for Preclinical Renal MRI: A Comprehensive Open-Access Protocol Collection to Improve Training, Reproducibility, and Comparability of Studies.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2021
Historique:
entrez: 21 1 2021
pubmed: 22 1 2021
medline: 27 3 2021
Statut: ppublish

Résumé

Renal MRI holds incredible promise for making a quantum leap in improving diagnosis and care of patients with a multitude of diseases, by moving beyond the limitations and restrictions of current routine clinical practice. Clinical and preclinical renal MRI is advancing with ever increasing rapidity, and yet, aside from a few examples of renal MRI in routine use, it is still not good enough. Several roadblocks are still delaying the pace of progress, particularly inefficient education of renal MR researchers, and lack of harmonization of approaches that limits the sharing of results among multiple research groups.Here we aim to address these limitations for preclinical renal MRI (predominantly in small animals), by providing a comprehensive collection of more than 40 publications that will serve as a foundational resource for preclinical renal MRI studies. This includes chapters describing the fundamental principles underlying a variety of renal MRI methods, step-by-step protocols for executing renal MRI studies, and detailed guides for data analysis. This collection will serve as a crucial part of a roadmap toward conducting renal MRI studies in a robust and reproducible way, that will promote the standardization and sharing of data.This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network funded by the European Cooperation in Science and Technology (COST) program of the European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.

Identifiants

pubmed: 33475991
doi: 10.1007/978-1-0716-0978-1_1
pmc: PMC9703281
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-23

Références

Invest Radiol. 2014 Aug;49(8):547-60
pubmed: 24651661
MAGMA. 2020 Feb;33(1):199-215
pubmed: 31768797
Pediatr Radiol. 2010 Feb;40(2):182-99
pubmed: 20012602
Nat Rev Nephrol. 2019 Mar;15(3):177-190
pubmed: 30518813
MAGMA. 2020 Feb;33(1):177-195
pubmed: 31676990
Sci Rep. 2016 Jul 21;6:30088
pubmed: 27439482
MAGMA. 2020 Feb;33(1):163-176
pubmed: 31758418
MAGMA. 2020 Feb;33(1):141-161
pubmed: 31833014
MAGMA. 2020 Feb;33(1):131-140
pubmed: 31628564
Radiographics. 2015 Jul-Aug;35(4):1208-30
pubmed: 26172361

Auteurs

Andreas Pohlmann (A)

Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany. a.pohlmann.phd@gmail.com.
Siemens Healthcare, Berlin, Germany. a.pohlmann.phd@gmail.com.

Susan J Back (SJ)

Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Andrea Fekete (A)

1st Department of Pediatrics, Semmelweis University, Budapest, Hungary.

Iris Friedli (I)

Antaros Medical, BioVenture Hub, Mölndal, Sweden.

Stefanie Hectors (S)

Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Neil Peter Jerome (NP)

Institute for Circulation and Diagnostic Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Department of Radiology and Nuclear Medicine, St. Olav's University Hospital, Trondheim, Norway.

Min-Chi Ku (MC)

Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Dario Livio Longo (DL)

Institute of Biostructures and Bioimaging (IBB), Italian National Research Council (CNR), Torino, Italy.

Martin Meier (M)

ZTL-Imaging Center, Hannover Medical School, Hannover, Germany.

Jason M Millward (JM)

Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.

João S Periquito (JS)

Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.

Erdmann Seeliger (E)

Institute of Physiology, Charité University Medicine Berlin, Berlin, Germany.

Suraj D Serai (SD)

Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Sonia Waiczies (S)

Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.

Steven Sourbron (S)

Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.

Christoffer Laustsen (C)

Department of Clinical Medicine, The MR Research Center, Aarhus, Denmark.

Thoralf Niendorf (T)

Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH